nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—CYP3A4—Esomeprazole—Barrett's esophagus	0.625	0.629	CbGbCtD
Tasosartan—CYP3A4—Omeprazole—Barrett's esophagus	0.368	0.371	CbGbCtD
Tasosartan—AGTR2—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.000557	0.0759	CbGpPWpGaD
Tasosartan—AGTR1—Arf6 signaling events—HGF—Barrett's esophagus	0.0005	0.0682	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—SST—Barrett's esophagus	0.00047	0.064	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000373	0.0509	CbGpPWpGaD
Tasosartan—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000351	0.0478	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—SST—Barrett's esophagus	0.000284	0.0387	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000268	0.0365	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.00024	0.0327	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—GAST—Barrett's esophagus	0.000234	0.0319	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RELA—Barrett's esophagus	0.000218	0.0297	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.000217	0.0296	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—GAST—Barrett's esophagus	0.000213	0.029	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000202	0.0275	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000202	0.0275	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.000183	0.0249	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.000181	0.0247	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—SST—Barrett's esophagus	0.000161	0.0219	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—SST—Barrett's esophagus	0.000146	0.0199	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000145	0.0198	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CXCL8—Barrett's esophagus	0.000143	0.0194	CbGpPWpGaD
Tasosartan—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.00014	0.019	CbGpPWpGaD
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000128	0.0174	CbGpPWpGaD
Tasosartan—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000126	0.0172	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GAST—Barrett's esophagus	0.000126	0.0171	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000122	0.0166	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000111	0.0151	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000104	0.0141	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—SST—Barrett's esophagus	9.27e-05	0.0126	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SST—Barrett's esophagus	8.62e-05	0.0117	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GAST—Barrett's esophagus	7.64e-05	0.0104	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	7.07e-05	0.00963	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GAST—Barrett's esophagus	6.94e-05	0.00945	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	6.63e-05	0.00904	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CXCL8—Barrett's esophagus	6.26e-05	0.00853	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CXCL8—Barrett's esophagus	5.69e-05	0.00775	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	5.51e-05	0.00751	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	5.44e-05	0.00741	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—SST—Barrett's esophagus	5.24e-05	0.00714	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—SST—Barrett's esophagus	4.76e-05	0.00648	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.74e-05	0.00646	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APC—Barrett's esophagus	4.56e-05	0.00622	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GAST—Barrett's esophagus	4.1e-05	0.00558	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CXCL8—Barrett's esophagus	3.61e-05	0.00492	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—RELA—Barrett's esophagus	3.56e-05	0.00486	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CXCL8—Barrett's esophagus	3.36e-05	0.00458	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SST—Barrett's esophagus	2.81e-05	0.00383	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TP53—Barrett's esophagus	2.06e-05	0.00281	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.04e-05	0.00278	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCL8—Barrett's esophagus	1.85e-05	0.00252	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APC—Barrett's esophagus	1.49e-05	0.00203	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGES—Barrett's esophagus	1.24e-05	0.00169	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RELA—Barrett's esophagus	1.16e-05	0.00158	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCL8—Barrett's esophagus	1.09e-05	0.00149	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	9.43e-06	0.00128	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	6.8e-06	0.000926	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TP53—Barrett's esophagus	6.72e-06	0.000915	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARG—Barrett's esophagus	3.1e-06	0.000423	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	2.44e-06	0.000332	CbGpPWpGaD
